BONETTI, MARCO
 Distribuzione geografica
Continente #
EU - Europa 5.326
NA - Nord America 4.875
AS - Asia 2.772
SA - Sud America 334
AF - Africa 110
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 11
Totale 13.440
Nazione #
US - Stati Uniti d'America 4.601
RU - Federazione Russa 1.314
CN - Cina 937
IE - Irlanda 789
IT - Italia 737
SG - Singapore 718
GB - Regno Unito 585
FI - Finlandia 544
UA - Ucraina 431
VN - Vietnam 367
BR - Brasile 258
DE - Germania 239
CA - Canada 216
SE - Svezia 213
HK - Hong Kong 201
FR - Francia 183
TR - Turchia 156
BG - Bulgaria 70
KR - Corea 66
IN - India 58
ZA - Sudafrica 50
MX - Messico 42
PL - Polonia 37
IL - Israele 35
IQ - Iraq 35
JP - Giappone 34
BD - Bangladesh 32
ES - Italia 28
CZ - Repubblica Ceca 26
ID - Indonesia 26
NL - Olanda 22
AR - Argentina 21
PK - Pakistan 21
BE - Belgio 18
TN - Tunisia 16
CL - Cile 15
DK - Danimarca 15
CH - Svizzera 14
SA - Arabia Saudita 12
AU - Australia 10
EU - Europa 10
PH - Filippine 10
EC - Ecuador 9
EG - Egitto 9
AT - Austria 8
LT - Lituania 8
TH - Thailandia 8
VE - Venezuela 8
CO - Colombia 7
JO - Giordania 7
UZ - Uzbekistan 7
KE - Kenya 6
MA - Marocco 6
MY - Malesia 6
PT - Portogallo 6
RO - Romania 6
AL - Albania 5
ET - Etiopia 5
GR - Grecia 5
HU - Ungheria 5
PE - Perù 5
BY - Bielorussia 4
CR - Costa Rica 4
KG - Kirghizistan 4
LK - Sri Lanka 4
NP - Nepal 4
PY - Paraguay 4
AZ - Azerbaigian 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
LV - Lettonia 3
NO - Norvegia 3
OM - Oman 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
UY - Uruguay 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
IR - Iran 2
JM - Giamaica 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BF - Burkina Faso 1
BJ - Benin 1
CY - Cipro 1
GY - Guiana 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 13.430
Città #
Dublin 789
Ashburn 692
San Jose 488
Helsinki 476
Singapore 386
Chandler 378
Southend 373
Jacksonville 346
Hefei 331
Dallas 273
Moscow 260
Ann Arbor 226
Milan 203
Hong Kong 188
Beijing 181
Toronto 173
Dearborn 171
Dong Ket 135
Salerno 130
New York 112
Wilmington 92
Edison 82
Boston 80
Lawrence 76
Lauterbourg 72
Ho Chi Minh City 71
Izmir 69
Seoul 66
Los Angeles 65
Woodbridge 63
Hanoi 59
Boardman 52
Houston 46
Johannesburg 46
Seattle 45
Redwood City 44
Modena 43
Mountain View 43
Fremont 37
Rome 37
São Paulo 37
Nanjing 34
Fairfield 32
Tel Aviv 32
The Dalles 31
Tokyo 28
Warsaw 28
Council Bluffs 27
Kunming 24
Falls Church 21
Frankfurt am Main 21
Jakarta 18
Orem 18
Chennai 16
Mexico City 16
London 15
Montreal 15
Ottawa 15
Santa Clara 15
Brussels 14
Da Nang 14
Denver 14
Jinan 14
Nuremberg 14
Atlanta 13
Haymarket 13
Munich 13
Phoenix 13
Stockholm 13
Amsterdam 12
Dhaka 12
Guangzhou 12
Dammarie 11
Assago 10
Auburn Hills 10
Bologna 10
San Francisco 10
Brooklyn 9
Mumbai 9
Norwalk 9
Shanghai 9
Wuhan 9
Chengdu 8
Chicago 8
Nanchang 8
Paris 8
Santiago 8
Torino 8
Amman 7
Bangkok 7
Erbil 7
Falkenstein 7
Istanbul 7
Poplar 7
Cairo 6
Cambridge 6
Como 6
Curitiba 6
Fuzhou 6
Jeddah 6
Totale 8.335
Nome #
A survival analysis of the last great European plagues: the case of Nonantola (Northern Italy) in 1630 417
Pandemics and socio-economic status : evidence from the plague of 1630 in Northern Italy 409
GiniInc: a Stata package for measuring inequality from incomplete income and survival data 364
The Gini concentration index for the study of survival 272
An analysis of the number of medical malpractice claims and their amounts 270
Clustering-based measurement of dependence 254
Neurocognitive assessment in obsessive compulsive disorder patients: adherence to behavioral decision models 253
A proposal for a two-step sampling design to oversample units responding to prescribed characteristics 221
A bivariate method for spatio-temporal syndromic surveillance 220
Longevity and concentration in survival times: the log-scale-location family of failure time models 216
The Gini Test for Survival Data in Presence of Small and Unbalanced Groups. 213
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: A randomized trial 206
A method-of-moments estimation procedure for categorical quality-of-life data with nonignorable missingness 205
A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data 202
Effect of the number of removed lymph nodes on prostate cancer recurrence and survival: evidence from an observational study 201
A multistate Markov chain model for longitudinal, categorical quality-of-life data subject to non-ignorable missingness 195
A bivariate method for spatio-temporal syndromic surveillance (article published in proceedings) 195
Biomarkers, subgroup evaluation, and clinical trial design 193
Asymptotic behavior of a set-statistic 190
Another STEPP in the right direction 189
Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial 187
A population-adjusted stable geospatial baseline for outbreak detection in syndromic surveillance (poster with abstract published in proceedings) 187
The Gini concentration test for survival data 185
A nonparametric scoring algorithm for identifying informative genes from microarray data 184
A permutation test for determining significance of clusters with applications to spatial and gene expression data 181
A new geometric approach to data analysis using the Minkowski polytope 181
Approximate Bayesian computation for the natural history of breast cancer, with application to data from a Milan cohort study 180
A note on the length-biased Weibull-Gamma frailty survival model 176
COVID-19 vaccine concerns about safety, effectiveness, and policies in the United States, Canada, Sweden, and Italy among unvaccinated individuals 176
Marshall–Olkin frailty survival models for bivariate right-censored failure time data 172
Parametric and nonparametric analysis of life courses: an application to family formation patterns 168
Cardiac safety of trastuzumab (H) in combination with pegylated liposomal doxorubicin (D) and docetaxel (T) in HER2-positive metastatic breast cancer (MBC): preliminary results of the Eastern Cooperative Oncology Group Trial E3198 (Abstract) 164
A small sample study of the STEPP approach to assessing treatment–covariate interactions in survival data. 161
Meta-STEPP: subpopulation treatment effect pattern plot for individual patient data meta-analysis 159
Exploring the association between misinformation endorsement, opinions on the government response, risk perception, and COVID-19 vaccine hesitancy in the US, Canada, and Italy 155
Freedom of choice to vaccinate and COVID-19 vaccine hesitancy in Italy 155
Parametric modelling of interpoint distance distributions, with an application to a mixture model for biosurveillance data 155
M statistic commands: interpoint distance distribution analysis. 152
Linking excess mortality to mobility data during the first wave of COVID-19 in England and Wales 152
Meta-STEPP with random effects 150
Duration of adjuvant chemotherapy for breast cancer: A joint analysis of two randomised trials investigating three versus six courses of CMF 149
The Gini Concentration Test for Survival Data 148
Tailoring adjuvant treatments for the individual breast cancer patient 147
Computing the exact distributions of some functions of the ordered multinomial counts: maximum, minimum, range and sums of order statistics 147
Patterns of treatment effects in subsets of patients in clinical trials 146
CEF is superior to CMF for tumours with TOP2A aberrations: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D. 145
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII 145
Risk factors for locoregional recurrence among breast cancer patients: Results from international breast cancer study group trials I through VII 142
Cross-national vaccine concerns and predictors of vaccine hesitancy in not-fully vaccinated individuals: findings from USA, Canada, Sweden, and Italy 142
Lorenz Curves and Treatment-Covariate Interactions in Clinical Trials 140
Real time spatial cluster detection using interpoint distances among precise patient locations 139
Interpoint distance distribution 139
MAX2 - A convenient index to estimate the average per patient risk for chemotherapy toxicity: Validation in ECOG trials 135
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis for continuous, binary, and count outcomes 134
The interpoint distance distribution as a descriptor of point patterns, with an application to cluster detection 133
Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPP 133
The choice of the number of bins for the M statistic 132
Evaluating markers for guiding treatment 132
Modelling menstrual status during and after adjuvant treatment for breast cancer 132
Evaluation of Treatment-Effect Heterogeneity Using Biomarkers Measured on a Continuous Scale: Subpopulation Treatment-Effect Pattern Plot (STEPP). 128
Discussion of the Frangakis and Rubin article 127
MAX2: a convenient index to estimate the average per patient risk of severe toxicity from a chemotherapy regimen. Testing in ECOG studies (Abstract) 125
Prognostic Value of Extracapsular Tumor Spread for Locoregional Control in Premenopausal Patients With Node-Positive Breast Cancer Treated With Classical Cyclophosphamide, Methotrexate, and Fluorouracil: Long-Term Observations From International Breast Cancer Study Group Trial VI 125
Deformable templates: a statistical setting 123
Early Start of Adjuvant Chemotherapy May Improve Treatment Outcome for Premenopausal Breast Cancer Patients With Tumors not Expressing Estrogen Receptors 122
The distribution of interpoint distances 121
Effect of glutathione S-transferase polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis results from the Roxbury Lupus Project 118
Enhanced power to detect bioterrorism with spatial clustering (abstract) 117
Identifying breast cancer patients at high risk for bone metastases 117
Power comparisons for an improved disease clustering test 115
Distance-based methods for spatial and spatio-temporal surveillance 115
Evaluation of age-specific causes of death in the context of the Italian longevity transition 114
Parametric models for interpoint distances and their use in biosurveillance 114
Principles of clinical trials 114
Epilocal: a real-time tool for local epidemic monitoring 113
Endocrine Responsiveness and Tailoring Adjuvant Therapy for Postmenopausal Lymph Node-Negative Breast Cancer: A Randomized Trial 111
Invited review of article: Jiang, Runchao; Lu, Wenbin; Song, Rui; Davidian, Marie (2017). On estimation of optimal treatment regimes for maximizing t-year survival probability. R. Stat. Soc. Ser. B. Stat. Methodol. 79 (2017), no. 4, 1165–1185. 110
The use of multiple addresses to enhance cluster detection 108
Features that predict responsiveness to chemotherapy and endocrine therapies 107
Subpopulation Treatment Effect Pattern Plot (STEPP) methods with R and Stata 106
The sparsity index in Poisson size-biased sampling: algorithms for the optimal unbiased estimation from small samples 105
The average uneven mortality index: building on the "e-dagger" measure of lifespan inequality 90
Totale 13.570
Categoria #
all - tutte 52.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021335 0 0 0 0 0 0 0 0 0 47 89 199
2021/2022764 85 208 12 18 32 38 35 71 56 55 84 70
2022/20231.861 85 44 35 119 143 117 60 110 991 29 77 51
2023/2024911 48 41 56 13 109 119 77 103 41 39 119 146
2024/20251.307 34 33 58 26 63 40 178 71 442 126 129 107
2025/20265.238 338 564 175 355 405 235 732 579 1.395 460 0 0
Totale 13.570